High-fidelity CRISPR–Cas9 nucleases with no detectable genome-wide off-target effectsBenjamin P. Kleinstiver, J. Keith Joung, Vikram Pattanayak et al.|Nature|2016Cited by 2.7k
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleasesShengdar Q. Tsai, J. Keith Joung, Long P. Le et al.|Nature Biotechnology|2014Cited by 2.3k
Engineered CRISPR-Cas9 nucleases with altered PAM specificitiesBenjamin P. Kleinstiver, J. Keith Joung, Michelle S. Prew et al.|Nature|2015Cited by 1.7k
Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibilityMin Yu, Daniel A. Haber, Aditya Bardia et al.|Science|2014Cited by 911
Broadening the targeting range of Staphylococcus aureus CRISPR-Cas9 by modifying PAM recognitionBenjamin P. Kleinstiver, J. Keith Joung, Michelle S. Prew et al.|Nature Biotechnology|2015Cited by 630